Spelling suggestions: "subject:"ignaling pathway"" "subject:"2signaling pathway""
101 |
Adjusting Wnt signaling, nové regulační mechanismy signální dráhy Wnt / Adjusting Wnt signaling, new regulatory mechanisms of the Wnt pathwayFafílek, Bohumil January 2012 (has links)
4 Abstract The Wnt pathway is one of the major signaling cascades contributing to multiple cellular processes during embryogenesis, and adult tissue homeostasis and regeneration. Moreover, aberrant activation of the Wnt signaling pathway is connected with development of neoplasia, notably colorectal cancer. The aim of the thesis was to identify new ways of the Wnt pathway regulation to understand better physiological as well as non-physiological mechanisms of Wnt signaling. The results are summarized in four publications. The first article deals with TROY, a member of tumor necrosis factor receptor family. We identified TROY as a Wnt target gene during our search for Wnt responsive genes in colorectal cancer cell lines. Additionally, we detected expression of Troy in tumors of two mouse models of intestinal cancer. In the healthy gut, Troy is produced in fast cycling intestinal stem cells where negatively regulates the Wnt pathway. The second study focuses on processing and posttranslational modification of murine Wnt1 and Wnt3a. Wnts are glycosylated and double acetylated by lipid adducts and our results revealed that O-linked acylation of serine is required for the subsequent S-palmitoylation of cysteine. Moreover, acylation of Wnts is connected with their signaling activity which is related to Wnt1 and...
|
102 |
Metabolismo oxidativo e estado redox tecidual dependente da função e do estado nutricional de operárias de Apis mellifera L. / Oxidative metabolism and redox state dependent on the function and nutritional status of Apis mellifera L. workersCervoni, Mário Sergio 03 December 2018 (has links)
As operárias de Apis mellifera realizam diferentes tarefas de acordo com a sua idade (polietismo etário), sendo que operárias jovens cuidam da cria e quando mais velhas forrageiam. Entretanto, tal transição não segue uma cronologia fixa, mas se ajusta às necessidades da colônia, especialmente as condições nutricionais, tanto da colônia quanto dos indivíduos. Nesse sentido, abordamos a questão de como o metabolismo oxidativo no corpo gorduroso das operárias, i.e., o centro do metabolismo intermediário destes insetos, está relacionado com alterações da função das operárias na colônia e como o mesmo responde a um estresse nutritivo imposto individualmente em duas fases, na fase larval e na fase adulta. Como métodos para avaliar a atividade mitocondrial e o estado redox das células do corpo gorduroso utilizamos um sistema de respirometria de alta resolução para medir o consumo de O2, e realizamos ensaios bioquímicos para quantificar a geração de espécies reativas de oxigênio (EROs), os níveis de óxido nítrico, o número de unidades mitocondriais, e eventuais danos oxidativos resultantes. Ademais, por meio de PCR quantitativa medimos a expressão relativa de genes ligados à biogênese mitocondrial, ao sistema antioxidante e à via de sinalização por hipóxia. Na comparação destes parâmetros entre operárias nutridoras e forrageiras avaliamos separadamente os três principais compartimentos do corpo (cabeça, tórax e abdômen) uma vez que esses estão diferencialmente relacionados a tais funções. Para os tecidos da cabeça observamos que as amostras de nutridoras apresentaram maior consumo de O2, associado a uma maior produção de EROs e expressão elevada dos genes da via de hipóxia, enquanto forrageiras apresentaram maiores quantidades de transcritos dos genes do sistema antioxidantes e menores níveis de danos oxidativos. Para os tecidos do tórax observamos nas forrageiras uma maior capacidade de produção de ATP, acompanhada de uma elevada expressão de genes codificadores de enzimas do sistema antioxidante e menores níveis de danos oxidativos. Com relação aos tecidos abdominais, as abelhas nutridoras apresentaram maior atividade mitocondrial, enquanto as amostras de forrageiras apresentaram maior número de unidades mitocondriais, elevados níveis EROs e também uma expressão elevada dos genes do sistema antioxidante e da via de hipóxia. Assim, os dados revelaram uma clara mudança na atividade mitocondrial e nos padrões redox teciduais associados a esta transição de polietismo etário. Também notamos diferenças nestes parâmetros para cada compartimento do corpo analisado, refletindo uma demanda energética diferencial em cada tecido. A segunda parte do projeto teve como objetivo avaliar os mesmos parâmetros redox em uma situação de restrição alimentar em três situações distintas. O primeiro grupo experimental foi constituído de larvas que sofreram restrição calórica por umperíodo de 10 horas. O segundo grupo foi composto por abelhas recém emergidas que sofreram ou não tal restrição calórica no período larval. O terceiro grupo consistiu de abelhas que sofreram ou não restrição calórica no período larval, e após emergirem foram mantidas em caixas até atingirem a idade de 7 dias, quando foram submetidos novamente a uma restrição calórica. Para o primeiro grupo, as larvas, verificamos que após o período de restrição calórica os genes relacionados com a biogênese mitocondrial e o sistema antioxidante apresentaram níveis de expressão menores comparadas com larvas controle. Observamos também que larvas que sofreram restrição calórica apresentaram menor consumo de O2 e menores níveis de EROs. Para o segundo grupo, as abelhas recém emergidas, não observamos nenhuma diferença na expressão de genes mitocondriais e do sistema antioxidante entre as que sofreram ou não restrição calórica na fase larval, demostrando uma recuperação nestes parâmetros após o período de metamorfose. No terceiro grupo, as abelhas de 7 dias foram submetidas a uma nova restrição calórica para observar se indivíduos que passaram por a situação de estresse no período larval apresentariam uma resposta mais imediata a um estresse nutricional na fase adulta. Os resultados do terceiro grupo revelaram que abelhas que haviam sido expostas a uma situação prévia de restrição calórica, apresentaram uma redução dos transcritos de genes ligados a biogênese mitocondrial e do sistema antioxidante quando comparados ao grupo que sofreu restrição calórica apenas na fase adulta. Em conjunto nossos dados sugerem que a restrição calórica é capaz de diminuir o metabolismo oxidativo e que existe uma resposta aparentemente adaptativa em indivíduos adultos que passaram por essa situação previamente durante o desenvolvimento larval. Assim, esses resultados podem servir para direcionar estudos futuros sobre a relação entre restrição calórica, metabolismo oxidativo e longevidade nesses insetos sociais. / Apis mellifera workers perform different tasks according to their age (age polyethism), where young workers care for the brood and older ones become foragers. However, this a transition does not follow a fixed chronology, but is fitted to the needs of the colony, especially the nutritional conditions of both, the colony and the individual bee. In this sense, we address the question of how oxidative metabolism in the fat body of the workers, e.g., the center of the intermediary metabolism of these insects, is related to changes in the function of the workers in the colony, and how these parameters responds to a nutritional stress imposed individually in two stages, in the larval and adult phase. For evaluating mitochondrial activity and the redox status of fat body cells we used a high resolution respirometry system to measure O2 consumption, and we performed biochemical assays to measure the generation of reactive oxygen species (ROS), levels of nitric oxide, the number of mitochondrial units, and eventual oxidative damages. Furthermore, using quantitative PCR, we measured the relative expression of genes linked to mitochondrial biogenesis, to the antioxidant system, and to the hypoxia signaling pathway. In the comparison of these parameters between nurse and forager workers, we evaluated separately the three main body compartments (head, thorax and abdomen), since these are differentially related to these functions. For the head tissues, we observed that nurses showed higher O2 consumption, associated with higher ROS production and elevated expression of hypoxia pathway genes, while foragers presented higher amounts of transcripts of the antioxidant system genes and lower levels of oxidative damages. For the thorax tissues we found in the foragers a greater capacity of ATP production, accompanied by a higher expression of genes encoding enzymes of the antioxidant system and lower levels of oxidative damage. With respect to the abdominal tissues, nurse bees presented higher mitochondrial activity, while foragers had a higher number of mitochondrial units, elevated ROS levels, and also a higher expression of genes related to the antioxidant system and hypoxia pathway. Thus, these data revealed a clear change in mitochondrial activity and redox tissue patterns associated with this transition of age polyethism. We also noticed differences in these parameters for each of the analyzed body compartment, reflecting a differential energy demand in each tissue. The second part of the project aimed to evaluate the same redox parameters in a food restriction condition in three distinct situations. The first experimental group consisted of larvae that experienced caloric restriction for a 10 hour period. The second group consisted of newly emerged bees that had or not experienced such a caloric restriction in the larval period. The third group consisted of bees that had experienced or not caloric restriction during the larval period, and after emergence were kept in boxes until reaching 7 days old, when they were resubmitted to another caloricrestriction. For the first group, the larvae, we found that after the period of caloric restriction, genes related to mitochondrial biogenesis and the antioxidant system presented lower levels of expression compared to control larvae. We also observed that larvae that had experienced caloric restriction presented lower O2 consumption and lower ROS levels. For the second group, newly emerged bees, we did not observe any differences in the expression of mitochondrial genes and the antioxidant system among those individuals that had experienced or not caloric restriction in the larval phase, indicating a recovery in these parameters after the period of metamorphosis. In the third group, the 7-day-old bees had experienced a new caloric restriction to see whether individuals that had been in a stressful situation during larval period would respond more readily to nutritional stress in adulthood. The results for this group showed that bees that had been exposed to a previous caloric restriction presented a reduction in the transcript levels of genes related to mitochondrial biogenesis and the antioxidant system when compared to the group that experienced caloric restriction only in adulthood. Taken together, our data suggest that caloric restriction is able to diminish the oxidative metabolism, and that there is a seemingly adaptive response in adult individuals that had previously experienced this situation during larval development. Thus, these results can serve to direct future studies on the relationship between caloric restriction, oxidative metabolism and longevity in these social insects.
|
103 |
Inibidores de mTOR são potencial terapia com alvo em células tronco tumorais para o carcinoma mucoepidermóide / Targeting cancer stem cells by mTOR inhibition in human mucoepidermoid carcinomaAndrade, Nathália Paiva de 09 June 2017 (has links)
O carcinoma mucoepidermóide (CME) é o tumor mais comum entre as neoplasias malignas de glândula salivar. Recentemente, uma rara população de células com características de multipotência, autorrenovação e potencial tumorigênico, denominadas como células tronco tumorais (CTT), foi descrita no CME. As CTT são resistentes as terapias atuais, e têm sido consideradas responsáveis pela recorrência e metástase, levando a um pior prognóstico para o paciente. A descoberta de que as CTT do CME superexpressam componentes da via de sinalização mTOR, levantou a hipótese que os pacientes poderiam ser beneficiados com o uso inibidores de mTOR como terapia para eliminação das CTT. O objetivo desse estudo foi avaliar o potencial uso de inibidores de mTOR como terapia para o CME com foco em CTT, assim como, investigar o funcionamento da via de sinalização mTOR e os efeitos moleculares do tratamento com inibidores dessa via nas CTT do CME. Foi realizada imuno-histoquímica para p-mTOR e p-S6K-1 em casos de pacientes diagnosticados com CME, os resultados foram correlacionados com os dados clínicos dos pacientes e também foi realizada dupla marcação por imunofluorescência para ALDH/p-mTOR. Estudos in vitro foram realizados em 3 linhagens de CME (UM-HMC-1, -3A, -3B) e com inibidores da via de sinalização mTOR. Após exposição aos inibidores, realizou-se ensaios de western blot (proteínas da via mTOR e BMI-1), citometria de fluxo para ALDH/CD44; salisfera; e apoptose, esse último comparando com quimioterápicos utilizados atualmente. Adicionalmente, foi utilizado o silenciamento genético de mTOR para confirmar os resultados obtidos com inibidores químicos. Por fim, foram realizados ensaios in vivo com as células silenciadas e com o inibidor de mTOR tensirolimo. Os resultados evidenciaram que a via de sinalização mTOR está ativa no CME, é correlacionada com pior prognóstico clínico e está superexpressa nas CTT. O tratamento com inibidores da via mTOR levaram a diminuição da fração de CTT, devido a perda de autorrenovação e apoptose das CTT. A apoptose, junto a diminuição de p-AKT revelada por western blot, sugeriram que esteja ocorrendo inibição de mTORC2 nas CTT, um importante componente na eficácia do tratamento com inibição de mTOR no câncer. Além disso, também houve redução de vasos sanguíneos, nichos das CTT, e diminuição do crescimento tumoral com uso de inibidores ou silenciando mTOR in vivo. Coletivamente, os resultados mostraram que a inibição de mTOR foi capaz de agir nas CTT por mecanismos diretos (indução de apoptose e diminuição da autorrenovação) e indiretamente através da redução de angiogênese, sugerindo que o uso de inibidores de mTOR no tratamento do CME é uma estratégia molecular eficiente para a redução de CTT, e uma potencial terapia adjuvante. / Mucoepidermoid carcinoma (MEC) is the most common tumor among malignant salivary gland neoplasms. Recently, a rare population of multipotent, self-renewing, and tumorigenic cells, termed cancer stem cells (CSC), was described in MEC. CSC are resistant to current therapies, and have been considered responsible for recurrence and metastasis, leading to worse patient prognosis. The discovery that CSC from MEC overexpressed the mTOR signaling pathway raised the hypothesis that use of mTOR inhibitors as therapy for CSC elimination could benefit patients. The objective of this study was to evaluate the potential use of mTOR inhibitors as a therapy for MEC targeting CTT, as well to investigate the functioning of mTOR signaling pathway and the molecular effects of treatment with mTOR inhibitors in MEC CSC. Immunohistochemistry was performed for p-mTOR and p-S6K-1 in paraffin samples from patients diagnosed with MEC and results were correlated with clinical data, in addition, co-immunoflorescence was performed for ALDH/p-mTOR. In vitro studies were performed with 3 MEC cell lines (UM-HMC-1, -3A, -3B) and with inhibitors of the mTOR signaling pathway. After exposure to inhibitors the following assays were performed: western blot (mTOR signaling pathway proteins and BMI-1), flow cytometry for ALDH/CD44, salispheres, and apoptosis, the latter comparing with currently chemotherapeutic agents used as treatment for cancer patients. In addition, mTOR genetically silent was used to confirm results with chemical inhibitors. Finally, in vivo assays were performed with knockdown cells and with mTOR inhibitor temsirolimus treatment. Results showed that mTOR signaling pathway is active in MEC, it is correlated with worse clinical prognosis and it is overexpressed in CSC. Treatment with inhibitors of mTOR signaling pathway led to a decrease in CSC fraction, caused by loss of self-renewal and apoptosis. Apoptosis, together with the decrease in p-AKT revealed by western blot, suggest that inhibition of mTORC2, an important compound in the efficacy of mTOR inhibition for cancer treatment, is occurring. In addition, there was reduction of blood vessels, CSC niches, and decreased tumor growth using mTOR inhibitors or silencing mTOR. Collectively, results showed that inhibition of mTOR was able to act in CSC by direct mechanisms (induction of apoptosis, decreased self-renewal) and indirectly through reduction of angiogenesis, suggesting that the use of mTOR inhibitors in treatment of MEC is an efficient molecular strategy to reduce fraction of CSC, and a potential therapy.
|
104 |
Análise da expressão e mecanismos de ação das proteínas Akt, Hsp90, mTOR e ciclina D1 em cultura de células de carcinoma epidermoide humano e células displásicas após irradiação com laser em baixa intensidade / The expression and action mechanisms of Akt, Hsp90, mTOR and cyclin D1 proteins in cultured cells of squamous cell carcinoma and dysplastic cells after being irradiated with low level laser therapySperandio, Felipe Fornias 06 December 2012 (has links)
O carcinoma de cabeça e pescoço é uma neoplasia maligna de origem epitelial que resulta em aproximadamente 500.000 novos casos por ano ao redor do mundo. Diversos estudos têm sido conduzidos de maneira a elucidar os mecanismos de proliferação e invasão desta doença, sendo a via de sinalização Akt/mTOR e proteínas relacionadas, apontada como uma das principais vias envolvidas em sua progressão. Sabe-se que células neoplásicas, bem como células de diferentes tecidos, podem ter seu comportamento modificado após terem sido irradiadas com laser em baixa intensidade (LLLT). Porém, os mecanismos de atuação da luz laser de baixa potência sobre estas células permanecem ainda não completamente esclarecidos. Portanto, o objetivo deste estudo foi o de analisar a viabilidade celular e expressão das proteínas Akt, pAkt, Hsp90, S6, pS6 e Ciclina D1 em duas linhagens celulares de carcinoma de boca (SCC9 e SCC25), bem como em uma linhagem de queratinócitos orais humanos com displasia (DOK) após irradiação com laser em baixa intensidade. O laser utilizado foi um diodo semicondutor de arseneto de Gálio e Alumínio (GaAlAs) operando nos comprimentos de onda vermelho (660nm) e infravermelho (780nm), com potência fixa em 40mW e três densidades de energia para cada comprimento de onda disponível: 2.05J/cm², 3.07J/cm² e 6.15J/cm². A análise de apoptose foi realizada por meio do teste de TUNEL e a expressão proteica foi obtida com imunofluorescência e western blotting. Após análise estatística por meio do método ANOVA dois critérios e testes de Tukey ou teste T de estudante, todos com nível de significância de 5%, pôde-se concluir que a LLLT induziu comportamentos distintos em cada uma das linhagens celulares utilizadas. Foi notado aumento, bem como diminuição da viabilidade celular, dependendo do comprimento de onda utilizado e das células irradiadas. A densidade de energia de 2.05J/cm² foi a que produziu efeitos mais significativos em SCC9. Para a linhagem celular SCC25, a dose mais relevante foi a de 3.07J/cm², enquanto que para a linhagem DOK, a dose de 6.15J/cm² causou efeitos mais proeminentes. Estas respectivas doses foram escolhidas para cada uma das linhagens para dar continuidade aos experimentos de Western Blotting e Imunofluorescência. Dentre os resultados mais relevantes obtidos com estas técnicas, pode-se citar a variação dos níveis de pS6 e Ciclina D1 para a linhagem DOK em determinados períodos. Já a linhagem SCC9 apresentou variação dos níveis de pAkt e Ciclina D1 nos períodos estudados. A linhagem SCC25 também teve as expressões de pAkt, pS6 e Ciclina D1 modificadas por LLLT. De maneira interessante, o aparecimento ou manutenção de uma isoforma de Hsp90 foi encontrado em SCC9 e SCC25 após irradiação laser. Por fim, a indução de apoptose foi detectada na linhagem SCC25. Em conclusão, pode-se dizer que a LLLT, como empregada neste estudo, foi capaz de aumentar a expressão de proteínas relacionadas à progressão e invasão em todas as linhagens estudadas. Além disso, a irradiação laser foi única, apesar de ter causado efeitos prolongados, algumas vezes até o último período estudado. / Head and neck squamous cell carcinoma (HNSCC) is an epithelial malignant neoplasm that accounts for approximately 500.000 new cases yearly around the world. Several studies have been conducted to elucidate the mechanisms of proliferation and invasion of this lesion, whereas the Akt/mTOR signaling pathway with its related proteins is being pointed out as one of the main pathways involved in HNSCC`s progression. Neoplastic cells, as well as cells that originate from different tissues may have their behavior modified by low level laser therapy (LLLT); however, the mechanisms through which the low level laser light interacts with these cells remain poorly understood. Thus, this study sought to evaluate the cell viability and the expression levels of Akt, pAkt, Hsp90, S6, pS6 and Cyclin D1 proteins in two oral squamous cell carcinoma cell lineages (SCC9 and SCC25) and in one oral dysplastic human keratinocyte cell line (DOK) after they had been treated with LLLT. The laser device was a semiconductor diode of Gallium and Aluminum Arsenate (GaAlAs), operating with wavelengths of 660nm (red) and 780nm (infrared), with a fixed power of 40mW and giving three different energy densities: 2.05J/cm², 3.07J/cm² and 6.15J/cm². Apoptosis was analyzed through TUNEL test and the protein expression was accessed with Immunofluorescence and Western blotting. After statistical analysis through two-way ANOVA and Tukey or Student`s T test, all of them with a level of significance of 5%, it was concluded that LLLT induced distinct behaviors to each of the studied cell lines. Increases and inhibitions in cell viabilities were detected depending on the wavelength and also on the irradiated cell line. The energy density of 2.05J/cm² produced the most significant findings over SCC9. On the other hand, in SCC25 the most relevant results were detected with 3.07J/cm², while the most prominent findings were seen with 6.15J/cm² when the cell line DOK was evaluated. In that way, these respective doses were chosen for each cell line to continue with Western blotting and Immunofluorescence. Among the most relevant findings, the variation of pS6 and Cyclin D1 levels can be cited for DOK in some evaluated periods. SCC9 presented both pAkt and Cyclin D1 variations in the studied periods. Besides that, SCC25 also had pAkt, pS6 and Cyclin D1 levels modified by LLLT. Interestingly, the appearance and maintenance of an Hsp90 isoform was found in SCC9 and SCC25 after laser irradiation. Moreover, the induction of apoptosis was detected for the SCC25 cell line. Finally, the LLLT employed herein was able to enhance the expression of proteins related to progression and invasion in all of the studied cell lines. In addition, there was a single laser irradiation, although it caused prolonged effects, sometimes through the latest evaluated period.
|
105 |
Contrôle de la masse et du phénotype musculaires en hypoxie : leçons tirées de modèles de croissance du muscle squelettique chez le rongeur / Control of muscle mass and phenotype in hypoxia : lessons drawn from muscle growth models in rodentChaillou, Thomas 08 December 2011 (has links)
Le muscle squelettique s'adapte en réponse à diverses influences en modulant sa masse et ses propriétés contractiles et métaboliques. Il est ainsi rapporté que l'hypoxie sévère a un effet délétère sur la masse et les capacités oxydatives du muscle, et pourrait ralentir la maturation du phénotype contractile au cours du développement post-natal. Cependant, les mécanismes de contrôle de cette plasticité musculaire ne sont pas clairement identifiés. Le but de ce travail était de déterminer le rôle de l'hypoxie environnementale sur le contrôle de la masse et l'adaptation du phénotype du muscle en croissance (hypertrophie de surcharge du plantaris après ablation de ses muscles agonistes et régénération du soléaire après lésions étendues induites par la notexine). L'exposition hypoxique limite transitoirement l'hypertrophie induite par la surcharge fonctionnelle, tandis qu'elle accentue la fonte musculaire en réprimant la formation et la croissance des néo-fibres au cours des étapes précoces de la régénération. Ces résultats seraient en partie expliqués par la désactivation partielle de la principale voie de protéosynthèse, la voie mTOR, par un mécanisme indépendant d'Akt. Parmi les inhibiteurs endogènes de mTOR étudiés (REDD1, BNIP-3 et l'AMPK), nous montrons que l'activation prononcée de l'AMPK en hypoxie pourrait réprimer l'activité de mTOR au cours de la régénération, alors que le mécanisme responsable de l'inhibition de mTOR n'a pas pu être identifié dans le modèle de surcharge. Le système protéolytique ubiquitine/protéasome-dépendant, évalué à partir de l'expression des atrogènes MURF1 et MAFbx, pourrait également expliquer en partie l'altération de l'hypertrophie de surcharge en hypoxie. Nos résultats soulignent par ailleurs que l'activité des cellules satellites serait réprimée au cours des premiers jours de régénération musculaire, conduisant à réduire la formation et la croissance des myotubes. Malgré cette perturbation précoce de la croissance musculaire, l'exposition prolongée en hypoxie ne limite pas l'hypertrophie de surcharge et la récupération de la masse du muscle lésé. Ceci démontre que les signaux anaboliques induits dans ces deux situations de croissance musculaire l'emportent très largement sur les signaux cataboliques de l'hypoxie. L'analyse des propriétés métaboliques et contractiles met en évidence que l'hypoxie altère les capacités oxydatives du muscle en croissance, mais les mécanismes impliqués dans cette réponse adaptative restent à identifier. Par ailleurs, l'hypoxie ne constitue pas un stimulus métabolique suffisant pour altérer la transition du phénotype contractile du muscle en surcharge et la récupération complète du phénotype contractile du muscle lésé. Elle contribue uniquement à ralentir très modérément et transitoirement l'adaptation phénotypique du muscle en surcharge, et à modifier le profil contractile du muscle durant la phase de dégénérescence musculaire. / Skeletal muscle adapts to various influences, by modulating both its mass and contractile and metabolic properties. It was reported that severe hypoxia impairs muscle mass and oxidative capacities and could reduce the fast-to-slow fiber transition during post-natal development. However, mechanisms involved in muscle plasticity during hypoxia exposure are not clearly identified. This work aimed to determine the role played by ambient hypoxia on the control of muscle mass and muscle phenotype during muscle growth (functional overload-induced hypertrophy of plantaris after removal of its synergist muscles and regeneration of soleus after extensive injury induced by notexin injection). Hypoxia exposure transiently minimizes the overload-induced hypertrophy, while it enhances the muscle-mass loss by repressing the formation and growth of nascent fibers during the early steps of regeneration. These results could be partly due to an impairment of the mTOR signaling activation, the main pathway involved in protein synthesis, independently of Akt. Among the endogenous repressors of mTOR studied (REDD1, BNIP-3 and AMPK), we show that the marked activation of AMPK in hypoxia could repress mTOR activity during regeneration, whereas the mechanism involved in mTOR inhibition remains unknown in the overload model. The ubiquitin/proteasome-dependant system, assessed from expression of the two atrogenes MURF1 and MAFbx, could also partly explain the hypoxia-induced alteration of muscle hypertrophy. Nevertheless, our findings show that activity of satellite cells could be repressed during the first days of regeneration, leading to reduce formation and growth of myotubes. Although muscle growth is early impaired, prolonged hypoxia exposure does not limit the overload-induced hypertrophy and the muscle mass recovery of injured muscle. This demonstrates that anabolic signals induced in these models of drastic muscle growth widely prevail on hypoxia-induced catabolic signals. The analysis of metabolic and contractile properties shows that hypoxia alters oxidative capacities in growing muscle, but mechanisms involved in this adaptive response remain to be elucidated. Moreover, hypoxia is not a sufficient metabolic stimulus to impair the fast-to-slow fiber transition in overloaded muscle, and the complete recovery of the contractile phenotype in injured muscle. It only contributes to transiently and modestly slow down the fast-to-slow fiber shift in overloaded muscle, and to modify the contractile profile of muscle during the degeneration phase.
|
106 |
Rôles des altérations des gènes CTNNB1 et de ZNRF3 dans les carsinomes de la corticosurrénale / Roles of CTNNB1 and ZNRF3 genes alterations in the development of adrenocortical carcinomaOmeiri, Hanin 21 March 2017 (has links)
Les carcinomes de la cortico-surrénale (CCS) sont des tumeurs de mauvais pronostic et les thérapies sont encore limitées. La chirurgie reste à ce jour le seul traitement efficace. La compréhension des mécanismes de la tumorigenèse cortico-surrénalienne et l'identification des gènes et des voies de signalisation impliquées sont nécessaires pour identifier de nouvelles cibles thérapeutiques. Ces dernières années, plusieurs études de génomique ont été réalisées sur des cohortes indépendantes de CCS et ont mis en évidence l'existence de deux groupes de CCS ayant des profils d’expression génique particuliers et associés à des pronostics de survie différents. Il a aussi été identifié de fréquentes mutations touchant les gènes TP53 et CTNNB1 (β-caténine). De plus, l'activation aberrante de la voie WNT/β-caténine est associée au groupe des CCS agressifs. Enfin, des analyses des altérations génomiques par puce SNP et le séquençage de l’exome de cohortes de CCS a permis de préciser les fréquences des mutations de TP53 (~18%) et CTNNB1 (~14%) mais a aussi mis en évidence des mutations et des délétions homozygotes au niveau du gène ZNRF3 (Zinc And Ring Finger 3) dans environs 20% des CCS. ZNRF3 a été montré comme jouant un rôle de régulateur négatif de la voie WNT/β-caténine. Par conséquent, la voie de signalisation WNT/β-caténine est la voie la plus fréquemment altérée dans les CCS (~40%). L’objectif de mon projet était d’étudier comment l’activation constitutive de la voie WNT/β-caténine pouvait participer à la tumorigenèse cortico-surrénalienne, puis d'essayer de comprendre plus spécifiquement le rôle des altérations de ZNRF3 dans le développement et/ou l'agressivité des CCS. En combinant des analyses de transcriptomes de modèles cellulaires et de cohortes de CCS, nous avons établi une signature robuste cortico-surrénalienne de l'activation de la voie WNT/β-caténine. Parmi les gènes de cette signature, nous avons montré que AFF3 était une cible transcriptionnelle de la β-caténine et qu'il était capable de transmettre en partie les effets oncogèniques de la voie WNT/β-caténine dans les cellules cortico-surrénaliennes. En effet, son invalidation entraîne l'apoptose et diminue la prolifération des cellules cortico-surrénaliennes à l'image de l'invalidation de la β-caténine. La surexpression d’AFF3 altère l’organisation des speckles nucléaires et la localisation de CDK9/CyclinT1 impliqués respectivement dans l'épissage des ARNm et la transcription des gènes. ZNRF3 est le gène le plus fréquemment altéré dans les CCS alors qu'il l'est très peu dans les autres types de cancers. ZNRF3 est une E3 ubiquitin ligase qui entraîne l'internalisation et la dégradation des récepteurs Frizzleds de la voie WNT. Nous avons montré que ZNRF3 agit bien comme un gène suppresseur de tumeur dans les cellules cortico-surénaliennes humaines H295R. En effet la surexpression de ZNRF3 diminue la prolifération et augmente l’apoptose cellulaire de ces cellules. Nous avons aussi montré qu'à l'image d'autres régulateurs négatifs de la voie WNT comme AXIN2, ZNRF3 est un gène cible de la voie WNT/β-caténine dans la corticosurrénale. De manière intéressante, les altérations du gène ZNRF3 ne sont pas retrouvées dans des tumeurs présentant une forte activation de la voie de signalisation WNT/β-caténine, suggérant l'implication d'autres voies de signalisation. Nous avons identifié des partenaires protéiques de ZNRF3 par des expériences d'immunoprécipitation / spectrométrie de masse. Nous avons montré que ZNRF3 interagit avec la sous unité catalytique de la pompe NA+/K+, ATP1A1. Cette interaction altère le fonctionnement de la pompe NA+/K+ conduisant à des modifications du flux de Ca2+ intracellulaire. L'ensemble de ces travaux a permis de mieux comprendre comment la voie WNT/β-caténine participe à l'agressivité des cancers de la corticosurrénale et de montrer qu'AFF3 est essentiel pour les effets oncogéniques de cette voie. (...) / Adrenocortical carcinomas are rare tumors with poor prognostic and limited therapy. Up to now, surgery remains the only curative therapy. A better understanding of tumor biology and molecular prognostic factors would help to select relevant therapeutic targets and to develop innovative therapeutic strategies. In the last years, different genomic studies on independent cohorts of ACC have identified two subgroups of cancers with two distinguished profiles of genes expression and two different survival rates. Frequents alterations of CTNNB1 and TP53 are identified in ACC. Moreover, aberrant activation of WNT/β-catenin pathway in ACC is associated with lower overall survival. Using a combination of genomic approaches, we and others have recently analyzed independent cohorts of ACC. These works confirmed recurrent alterations in CTNNB1 (~14%) and TP53 (~18%), but also revealed new loci not previously reported to be altered in ACC. Strikingly, ZNRF3 (zinc and ring finger 3) was the most frequently altered gene (~20%). ZNRF3 encodes a protein that acts as a negative regulator of Wnt/β-catenin pathway. The Wnt/β-catenin pathway represents the most frequently altered pathway in ACC (~40%). The aim of my project was to study how the aberrant activation of WNT/β-catenin pathway could participate to adrenal tumorigenesis and then to identify more specifically the role of ZNRF3 alterations in development/aggressiness of ACC. By a combination of transcriptomic analysis on two cohorts of ACC and on H295R adrenocortical cells, we identified a list of genes whose expression is correlated to the WNT/β-catenin activation. Among these genes, we show that AFF3 is essential to mediate the effect of activation the WNT/β-catenin pathway in adrenocortical cancer. Indeed, AFF3 is a direct target gene of β-catenin and its silencing in H295R adrenocortical cells induces a decreased cell proliferation and an increased apoptosis similar to that induced by β-catenin silencing. Moreover, AFF3 overexpression altered the structure of nuclear speckles and the localization of CDK9/CyclinT1, which are respectively involved in mRNA splicing and transcription. ZNRF3 (zinc and ring finger 3) was the most frequently altered gene (20%) in ACC. ZNRF3 had never been frequently associated with other tumour types. ZNRF3 encodes a protein that had been described as cell-surface transmembrane E3 ubiquitin ligases, acting as negative regulators of Wnt/β-catenin signaling, by promoting the degradation of Wnt ligand receptors (Frizzled receptors). We show that ZNRF3 act as a tumor suppressor gene in adrenocortical cell line H295R. Indeed the overexpression of ZNRF3 decreases cell proliferation and increases apoptosis. We demonstrate also that ZNRF3 is a target gene of WNT/β-catenin pathway. ZNRF3 alterations have less effect on expression of WNT/β-catenin target genes than CTNNB1 mutations in ACC. Moreover, our results with ZNRF3 overexpression in H295R adrenocortical cells suggest that ZNRF3 is also involved in βcatenin independant-pathway(s) to mediate its effects on apoptosis. Using mass spectrometry analysis, we identified that ZNRF3 interacts with ATP1A1 (ATPase Na+/K+ Transporting Subunit Alpha 1), affecting the activity of the Na+/K+ ATPase pump in adrenocortical cells. These results provide a better understanding of the biological process of WNT/βcatenin pathway activation in ACC with AFF3 as new target of this pathway. Moreover, our data provide insight into the tumor suppressor role of ZNRF3 in ACC and uncovers an additional role of ZNRF3 on Na+/K+ ATPase pump activity.
|
107 |
Multiple outcomes for PI3K/Akt/mTOR targeting in non-Hodgkin lymphomaMüller, Anja 25 August 2015 (has links)
Wachstumsfaktor bedingte Aktivierung des PI3K/Akt/mTOR Signalweg wirkt positiv auf Vermehrung und Überleben. Konstitutive Aktivierung des Signalweges in NHL ist jedoch an Tumorprogression und Therapieresistenz beteiligt. Am Zelllinienmodell wurden zwei mögliche Therapiestrategien der PI3K/Akt/mTOR Inhibition erprobt, PI3K Inhibition mit BKM120 und horizontale Kombination von Zytostatika mit PI3K/Akt/mTOR Inhibitoren Erstens, BKM120 hat Antitumoraktivität in NHL und induziert Zelltod. Auf molekularer Ebene führt BKM120 vermittelte Dephosphorylierung von CDK1 an Y15 zur Aktivierung des M-Phase Komplex CDK1/Zyklin B und Eintritt in die Mitose. Parallel erlaubt die Degradation von Zyklin A und Hochregulation von Zyklin B Progression bis zur Metaphase, hemmt jedoch die Transition in die Anaphase. Anhaltender Metaphasearrest bewirkt programmierten Zelltod über den intrinsischen Signalweg der Apoptose durch Hochregulation der BH3-onlys Puma und Hrk, Aktivierung von Bax/Bak und proteolytische Spaltung von Caspase 9. Verlust von Bax/Bak oder Caspase Inhibition schützt vor BKM120 vermitteltem Zelltod. Bax/Bak defiziente Zellen, welche zusätzlich p53 Mutationen aufweisen, werden polyploid. Die Polyploidie ist ATM-MEK1/2 abhängig und kann mit Caffeine oder U0126blockiert werden. Zur Vermeidung von Polyploidie bedingter Tumorprogression, sollte BKM120 nur in Verbindung mit MAPK/ATM Inhibitoren verwendet werden. Zweitens. Horizontale Kombination PI3K/Akt/mTOR Inhibitoren mit cytotoxischen Substanzen schützt vor Apoptose. Der Schutzeffekt tritt auschließlich bei niedrigen Konzentration auf und ist unabhängig von der Art des Inhibitors bzw. Ebene der Inhibition. Das Onkogen und NFkB Target Pim-2 ist möglicherweise am Schutzmechanismus beteiligt. Durch die PI3K/Akt/mTOR vermittelte Pim-2 Regulation ergibt sich eine neue Rückkopplungsschleife. Im Fazit erschwert die Komplexizität des PI3K/Akt/mTOR Signalweges die Etablierung von Therapien. / Growth factor mediated activation of the PI3K/Akt/mTOR pathway positively regulates proliferation and survival. Constitutive activation in NHL, however, is correlated with tumor progression and therapeutic resistance. Therefore, two possible strategies were tested in a cell line model system, Inhibition of PI3K with BKM120 and PI3K/Akt/mTOR Inhibition in addition to cytostatic drug administration. First, it is demonstrated that the pan PI3K inhibitor BKM120 has antitumor activity in NHL and induces cell death. On molecular level, BKM120 mediated dephosphorylation of CDK1 on Y15 causes activation of the M-phase complex CDK1/Cyclin B and entry into mitosis. In parallel, degradation of Cyclin A and Upregulation of Cyclin B enables progression into metaphase but inhibits transition into anaphase. Prolonged metaphase arrest induces programmed cell death via the intrinsic apoptosis pathway by upregulation of the BH3-onlys Puma and Hrk, activation of Bax/Bak and proteolytic cleavage of caspase-9. Loss of Bax/Bak or caspase inhibition protects from BKM120 induced apoptosis. Bax/Bak deficient cells with additional p53 mutation become polyploid. This polyploidy is ATM-MEK1/2 dependent and can be blocked with Caffeine or U0126. To prevent polyploidy related tumor progression, BKM120 should administered only in combination with ATM or MEK inhibitors. Second, combination of PI3K/Akt/mTOR inhibitors with cytotoxic agents protects from apoptosis. The protective effect is only detectable with low PI3K/Akt/mTOR inhibitor concentrations and independent of inhibitor type or cascade level. The oncogene and NFkB target is possibly involved in apoptosis protection and inhibition of NFkB neutralizes the protective effect. PI3K/Akt/mTOR mediated Pim-2 regulation reveals a new feedback loop within the pathway. In conclusion, the complexity of the PI3K/Akt/mTOR pathway impedes therapeutic targeting.
|
108 |
Via Wnt/?-catenina em tumores adrenocorticais pediátricos / Wnt/?-catenin signaling pathway in childhood adrenocortical tumorsLetícia Ferro Leal 21 July 2011 (has links)
Introdução: Em crianças das regiões Sul e Sudeste do Brasil há uma incidência elevada de tumores adrenocorticais (TAC). Anormalidades da ?-catenina tem sido encontradas em TAC em adultos e sugerem a ativação da via Wnt/ -catenina nestes tumores. No entanto, não há estudos avaliando o papel desta via em casuísticas de TAC pediátricos. Objetivos: Avaliar o papel da via Wnt/catenina e mutações do gene CTNNB1 na tumorigênese adrenocortical pediátrica. Indivíduos, Material e Métodos: Foram avaliados 62 pacientes pediátricos com TAC oriundos de dois centros de referência. Controles: córtex adrenal de indivíduos jovens com morte acidental. Avaliou-se a presença de mutação nos genes TP53 e CTNNB1. A expressão de genes da via Wnt (CTNNB1, o ligante WNT4, os inibidores SFRP1, DKK3 e AXIN1, o fator de transcrição TCF7 e os genes-alvo MYC e WISP2) foi avaliada por qPCR, utilizando-se o método de 2-Ct. Adicionalmente, a expressão de proteínas da via Wnt/-catenina e P53 foi avaliada por imunoistoquímica. Avaliou-se a relação entre possíveis anormalidades moleculares com o fenótipo clínico e o desfecho. Resultados: A sobrevida geral foi maior em pacientes menores que 5 anos de idade (p<0.0001) e em pacientes com estágios tumorais menos avançados (p<0.0001). A mutação P53 p.R337H foi encontrada em 87% dos pacientes e não se associou com características clinicopatológicas ou desfecho. Mutações do gene CTNNB1 foram encontradas em 4/62 (6%) TAC, todos carreadores da mutação P53 p.R337H. Houve associação entre óbito e presença de mutações do gene CTNNB1 (p=0,02). Acúmulo difuso da -catenina foi observado em 71% dos TAC, a maioria sem mutações do CTNNB1. Comparados a adrenais normais, os TAC apresentaram aumento da expressão do RNAm de CTNNB1 (p=0.008) e diminuição da expressão de genes inibidores da via Wnt: DKK3 (p<0.0001), SFRP1 (p=0.05) e AXIN1 (p=0.04). Com relação aos genes-alvo da via Wnt/-catenina, TAC apresentaram expressão aumentada de WISP2 e baixa expressão de MYC. Maior sobrevida geral foi associada à expressão baixa de SFRP1 (p=0.01), WNT4 (p=0.004) e TCF7 (p<0.01). Conclusões: Em TAC pediátricos, mutações somáticas ativadoras do gene CTNNB1 são pouco freqüentes e parecem estar associadas à maior ocorrência de óbito. Mesmo na ausência de mutações do gene CTNNB1, estes tumores apresentaram acúmulo de -catenina e do gene-alvo WISP2 e expressão reduzida de inibidores da via Wnt (DKK3, SFRP1 e AXIN1). Estes dados demonstram evidências de anormalidades na via Wnt/-catenina em TAC pediátricos, mesmo na ausência de mutações do gene CTNNB1. É provável que outros eventos genéticos afetando a via Wnt/-catenina estejam envolvidos na tumorigênese adrenocortical pediátrica / Context: CTNNB1 mutations and activation of Wnt/-catenin pathway are frequent in adult adrenocortical tumors (ACTs) but data on childhood ACTs are lacking. Objective: To investigate Wnt/-catenin pathway abnormalities and CTNNB1 mutations in childhood ACTs. Patients and Methods: Clinicopathological findings and outcome of 62 childhood ACTs patients were analyzed regarding to CTNNB1/ -catenin mutations and to the expression of Wnt-related genes (CTNNB1, a Wnt ligand: WNT4, Wnt inhibitors: SFRP1, DKK3 and AXIN1, a transcription factor: TCF7, and target genes: MYC and WISP2) by qPCR and immunohistochemistry. Results: Overall survival (OS) was higher in patients younger than 5 years (p<0.0001) and associated with less advanced tumoral stage (p<0.0001). The p.R337H P53 mutation, found in 87% of the patients, was not associated with clinicopathological findings or outcome. CTNNB1 activating mutations were found in only 4/62 ACTs (6%), all of them harboring TP53 mutation. There was association between the presence of CTNNB1 mutation and death (p=0.02). Diffuse -catenin accumulation was found in 71% of ACTs, most of them without CTNNB1 mutation. CTNNB1 mutated ACTs presented weak/moderate -catenin accumulation. Compared to normal adrenals, ACTs presented increased expression of CTNNB1 (p=0.008) and underexpression of Wnt inhibitor genes: DKK3 (p<0.0001), SFRP1 (p=0.05) and AXIN1 (p=0.04). With regards to Wnt/-catenin target genes, ACTs presented lower expression of MYC but increased expression of WISP2. Higher overall survival was associated with underexpression of SFRP1 (p=0.01), WNT4 (p=0.004) and TCF7 (p<0.01). Conclusions: In childhood ACTs, CTNNB1 mutations are rare and appear to be associated with poor prognosis. Regardless of CTNNB1 mutations, these tumors presented reduced expression of Wnt inhibitor genes (DKK3, SFRP1 and AXIN1) and increased expression of CTNNB1 and a target gene, WISP2. Thus, besides CTNNB1 mutations, additional genetic events affecting the Wnt/-catenin pathway may be involved in childhood adrenocortical tumorigenesis.
|
109 |
Baixos níveis de esclerostina: preditor de processo inflamatório persistente em pacientes com espondilite anquilosante sob terapia anti-TNFα / Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-TNF therapySaad, Carla Gonçalves Schahin 28 November 2012 (has links)
Introdução: Baixas concentrações séricas de esclerostina foram descritas em pacientes com Espondilite Anquilosante (EA). No entanto, não existem dados sobre a importância deste inibidor da via de sinalização Wnt em pacientes com EA durante o tratamento com anti fator de necrose tumoral alfa (TNFa). Objetivos: Avaliar longitudinalmente os níveis séricos de esclerostina e sua associação com inflamação e densidade mineral óssea (DMO) em pacientes com EA em tratamento com anti-TNFa. Métodos: Trinta pacientes com EA em atividade foram avaliados no início, 6 e 12 meses, após terapia anti-TNFa em relação aos parâmetros clínicos (BASDAI, BASFI, BASMI e ASQoL), marcadores inflamatórios e dano radiológico basal (mSASSS). Trinta indivíduos saudáveis pareados por idade e sexo constituíram o grupo controle. As análises laboratoriais de esclerostina e da ligação de esclerostina ao receptor LRP6 e a DMO foram realizadas nos pacientes nos mesmos períodos de avaliação e comparadas aos controles. Resultados: Na avaliação inicial, pacientes com EA apresentavam menores concentrações séricas de esclerostina [60,5 (32,7) vs. 96,7 (52,9) pmol/l,P=0,002] e níveis similares de ligação de esclerostina ao receptor LRP6 (P=0,387) em relação aos controles. Foi observado melhora do BASDAI, BASFI, BASMI, ASQoL comparando tempo basal vs. 6 vs. 12 meses (P<0,01). Concomitantemente, observou-se um aumento gradual da DMO da coluna lombar (P<0,001) e no início do estudo os pacientes apresentavam uma correlação positiva entre avaliação radiológica basal (mSASSS) e a DMO da coluna lombar (r=0,468, P<0,01). Foi observada também uma redução dos marcadores inflamatórios comparando tempo basal vs. 6 vs. 12 meses (P<0,01). Os níveis de esclerostina aumentaram progressivamente após o tratamento com anti-TNFa [60,5 (32,7) vs. 67,1 (31,9) vs. 72,7 (32,3) pmol/l, P<0,001]. Entretanto, após 12 meses de terapia anti-TNFa as concentrações séricas de esclerostina permaneceram significativamente mais baixos em relação os controles [72,7 (32,3) vs. 96,7 (52,9) pmol/l, P=0,038]. Além disso, aos 12 meses, os níveis séricos de esclerostina ficaram mais baixos nos 10 pacientes que ainda apresentavam proteína C reativa elevada (PCR=5mg/l), comparados aos pacientes que apresentaram normalização dos níveis de PCR (P=0,004). Interessantemente, estes 10 pacientes com inflamação persistente já apresentavam concentrações séricas mais baixas de esclerostina quando comparados aos demais pacientes (P=0,023) antes do tratamento com anti- TNFa. A análise de regressão logística demonstrou que os pacientes com EA com níveis baixos de esclerostina apresentam um risco aumentado de apresentar PCR alta após 12 meses de tratamento (odds ratio = 7,43, 95% IC 1,23-45,01, P=0,020) quando comparados aos pacientes com níveis altos de esclerostina no tempo basal. Conclusão: Concentrações persistentemente baixas de esclerostina estão associados a inflamação contínua em pacientes com EA tratados com terapia anti-TNFa. / Introduction: Sclerostin levels have been reported to be low in ankylosing spondylitis (AS), but there is no data regarding the possible role of this Wnt inhibitor during anti tumor necrosis factor alpha (TNFa) therapy. Objectives: The present study longitudinally evaluated sclerostin levels, inflammatory markers and bone mineral density (BMD) in AS patients under anti-TNFa therapy. Methods: Thirty active AS patients were assessed at baseline, 6 and 12 months after anti-TNFa therapy regarding clinical parameters (BASDAI, BASFI, BASMI and ASQoL), inflammatory markers, BMD and baseline radiographic damage (mSASSS). Thirty age- and sex-matched healthy individuals comprised the control group. Patients\' sclerostin levels, sclerostin binding LRP6 and BMD were evaluated at the same time points and compared to controls. Results: At baseline, AS patients had lower sclerostin levels [60.5 (32.7) vs. 96.7 (52.9) pmol/l, P=0.002] and comparable sclerostin binding to LRP6 (P=0.387) than controls. Improvement of BASDAI, BASFI, BASMI, ASQoL was observed at baseline vs. 6 vs. 12 months (P<0.01). Concomitantly, a gradual increase in spine BMD (P<0.001) and a positive correlation between baseline mSASSS and spine BMD was found (r=0.468, P<0.01). Inflammatory parameters reduction was observed comparing baseline vs. 6 vs. 12 months (P<0.01). Sclerostin levels progressively increased [60.5 (32.7) vs. 67.1 (31.9) vs. 72.7 (32.3) pmol/l, P<0.001] after anti-TNFa treatment. At 12 months, the sclerostin levels remained significantly lower in patients compared to controls [72.7 (32.3) vs. 96.70 (52.85) pmol/l, P=0.038]. Moreover, sclerostin serum levels at 12 months were lower in the 10 patients with high CRP (=5mg/l) compared to the other 20 patients with normal CRP (P=0.004). Of note, these 10 patients with persistent inflammation also had lower sclerostin serum levels at baseline compared to the other patients (P=0.023). Univariate logistic regression analysis demonstrated that AS patients with lower sclerostin serum levels had an increased risk to have high CRP at 12 months (odds ratio=7.43, 95% CI 1.23-45.01, P=0.020) than those with higher sclerostin values. Conclusion: Persistent low sclerostin levels may underlie continuous inflammation in AS patients under anti-TNFa therapy.
|
110 |
Rôle du facteur d’initiation eIF3h dans la réinitiation de la traduction et dans la pathogénèse virale chez les plantes / The role of eukaryotic initiation factor eIF3h in translation reinitiation and viral pathogenesisMakarian, Joelle 02 December 2016 (has links)
La réinitiation de la traduction est un mécanisme permettant de traduire des ORF qui sont présents dans la région leader de différents ARNm cellulaires (uORF). La majorité des cas de réinitiation de la traduction chez les eucaryotes concerne des uORF de petite taille. Des stratégies alternatives ont été développées, entre autres par les virus, afin de réinitier la traduction après un long uORF. Le virus de la mosaïque du chou-fleur (CaMV) exprime un ARNm polycistronique codant la totalité des protéines virales. L’une d’entre elle, la protéine TAV (TransActivateur/Viroplasmine) est un facteur essentiel qui rend possible la réinitiation de la traduction après de longs ORF et qui, de plus, active la protéine kinase TOR. La sous-unité h du facteur d’initiation de la traduction eIF3, requise pour promouvoir la reinitiation après un petit ORF chez les plantes, a été identifiée comme étant une nouvelle cible de phosphorylation de la voie de signalisation de TOR. L’objectif principal de ma thèse a été d’élucider la fonction de la protéine eIF3h dans la réinitiation après un petit ORF ainsi que dans la réinitiation de la traduction, assurée par TAV, après un long ORF. Nous avons exploité les lignées transgéniques eif3h-1 d’Arabidopsis exprimant la protéine eif3h tronquée de son extrémité C-terminale, qui sont déficientes pour la réinitiation mais pas pour l’initiation de la traduction. Nous avons montré que la phosphorylation de eIF3h est essentielle pour stabiliser eIF3 au niveau des ribosomes durant l’élongation, ce qui favorise la ré-acquisition par le ribosome de facteurs nécessaires à la réinitiation de la traduction, et que la délétion de sa région Ct abolit son intégration dans le complexe eIF3. De plus, nous avons montré que eIF3h, la cible de la voie de signalisation de TOR, interagit avec S6K1. Des protoplastes préparés à partir des plantes mutantes eif3h-1 sont incapables de promouvoir la réinitiation après de longs ORF en présence de TAV. La surexpression de eIF3h, indifféremment de son état de phosphorylation, est indispensable pour restaurer la reinitiation assurée par TAV dans les protoplastes eif3h-1. Par ailleurs, les plantes eif3h-1 déficientes dans la réinitiation, sont résistantes à l’infection par le CaMV démontrant l’importance de eIF3h pour la réplication du CaMV. En revanche, ces plantes eif3h-1 peuvent être infectées par d’autres virus dont la traduction de l’ARN génomique est coiffe- ou IRES-dépendante. Ainsi, nos résultats suggèrent que eIF3h est un facteur de reinitiation important aussi bien pour la reinitiation après un petit qu’après un long ORF (controlée par TAV), et que TAV exploite cette machinerie cellulaire, et plus particulièrement TOR et eIF3h, pour exprimer ses propres protéines par réinitiation de la traduction. / Translation of mRNAs that harbor upstream open reading frames (uORFs) within their leader regions operates via a reinitiation mechanism. In plants, reinitiation is up regulated by the target of rapamycin (TOR) signaling via phosphorylation of the subunit h of initiation factor 3 (eIF3). The eif3h-1 mutant expressing the C-terminally truncated eIF3h while maintaining high translation initiation efficiency is not active in reinitiation. Cauliflower mosaic virus (CaMV) pregenomic polycistronic RNA is translated via an exceptional mechanism of reinitiation after long ORF translation under control of CaMV protein TAV, which ensures activation of TOR. To find the link between underlying mechanisms, we examined eIF3h function in cellular and viral context. Here we show that eIF3h, if phosphorylated, has a role in recruitment of eIF3 into actively translating ribosomes that is a prerequisite for formation of reinitiation-competent ribosomal complexes. C-terminal truncation of eIF3h abolished its integration into the eIF3 complex and eIF3 loading on polysomes as manifested by the eIF3 core subunit c. We also show that eIF3h as a putative target of TOR/S6K1 binds S6K1 in vitro. eIF3h phosphorylation is not required for eIF3 complex formation. We demonstrated that eIF3h is essential for TAV to activate reinitiation after long ORF translation. Protoplasts derived from eif3h-1 mutant failed to support TAV function in reinitiation, which is restored only upon overexpression of recombinant eIF3h indifferent to its phosphorylation status. eif3h-1 mutant defective in reinitiation was found resistant to CaMV infection suggesting that eIF3h is critical for virus amplification. In contrast, viruses that evolve translation initiation dependent on either cap or the internal ribosome entry site infect reinitiation deficient mutant. Thus, we conclude that TAV exploits the basic cell reinitiation machinery, particularly TOR and eIF3h, to overcome cellular barriers to reinitiation after long ORF translation.
|
Page generated in 0.0638 seconds